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Biodegradable porous silicon (pSi) is under 
assessment for the controlled release of both 
proteins and poorly-soluble API formulations. 
Super-critical drying of ultrahigh porosity (90%) 
porous silicon is shown here to preserve much 
higher mesopore volumes (up to 4mL/g) and surface 
areas (up to 600m2/g) than achievable with standard 
air drying. The payloads and physical state of the 
model drug (S) (+) ibuprofen, as loaded within a 
super-critically dried porous silicon carrier matrix, 
were quantified and assessed using TGA, DSC, 
cross-sectional EDX, XRD, Raman mapping and 
FT-IR. In-vitro biodegradability was assessed using 
molybdenum blue assay and drug release using RP-
HPLC. Entrapped drug payloads as high as 70%w/w 
have been achieved, substantially higher than values 
reported for other mesoporous materials. The 
entrapped (S) (+) ibuprofen showed faster release 
than bulk (S) (+) ibuprofen. 
 
INTRODUCTION 
It is estimated that 40% of new drug 
compounds may be regarded as poorly-soluble, with 
that percentage even higher for certain therapeutic 
classes1. Controlled release systems have gained 
increased recognition as an alternative way to 
deliver APIs falling under Class II of the 
classification system (low aqueous solubility or high 
intestinal permeability)2.  
Non-polymeric biodegradable matrix 
systems have an advantage over reservoir systems in 
the avoidance of dose dumping of the API; 
moreover, polymeric encapsulants are not required 
to control the release of the active drug.  One key 
function of any controlled drug delivery system 
should be the capability to carry a high payload of 
the API. A second is to control the release of the 
loaded API in a desired way by enhancing the 
dissolution behaviour. Several therapeutically active 
APIs have been loaded in mesoporous materials3,4 
out of which Class II drugs have been studied most, 
mainly because their dissolution can be improved by 
mesoporous carriers. Payloads as high as 50% w/w 
have been reported for mesoporous carriers4. In this 
study, we report the development of a novel super-
critically dried form of biodegradable porous silicon, 
an ‘aerocrystal’5. With high surface area and high 
pore volume, such an aerocrystal has the ability to 
carry high drug payloads whilst offering nano-




Porous silicon layers were prepared on 
silicon wafers (p-type, 5-20 mcm resistivity) by 
anodisation6 and electrochemically detached from 
the substrate. Super-critical drying of the layers 
(using a Quorum Technologies Ltd K850 dryer) was 
carried out with carbon dioxide. After drying, the 
hydrophobic sample was rendered hydrophilic by 
thermal oxidation in a 1% O2 (in N2) gas mixture at 
600⁰C for 16hr. Pore characteristics of the resulting 
aerocrystals were determined by gas 
adsorption/desorption analysis. Biodegradability was 
assessed in-vitro over 15 days under sink conditions 
with tris buffer, pH 7.4 and 37⁰C. 
A melt loading technique was used for both 
flakes and powders.  To the molten mass of (S) (+) 
ibuprofen at 80⁰C, the aerocrystal was added under 
stirring to ensure a homogeneous mixture. The 
loaded co-formulation was then gently ground in a 
mortar and pestle to separate agglomerated particles. 
Studies were conducted on both hydrophobic as-
anodised aerocrystal flakes (TGA, DSC, EDX, MB 
assay) and hydrophilic aerocrystal powders (TGA, 
DSC, XRD, FTIR, Raman, HPLC). 
 
RESULTS AND DISCUSSION 
From the gas adsorption/desorption 
isotherms, the surface area, pore volume, and 
average pore diameter of the main sample used for 
release profiling were calculated to be, respectively: 
587m2/g, 3.837mL/g and 26.1nm before oxidation 
and 421m2/g, 2.277mL/g and 21.5nm after 
oxidation.  
The total loading of (S) (+) ibuprofen in this 
sample was found to be 74.6% by TGA. DSC was 
used to distinguish between the melting endotherm 
of (S) (+) ibuprofen inside the pores and on the 
surface. 
SEM imaging and EDX analysis, in cross-
section, was carried out after cleaving another 
loaded oxidized porous silicon layer (573m2/g, 
4.011mL/g, 28nm before oxidation and 415m2/g, 
2.691mL/g, 26nm after oxidation); by revealing a 
freshly-exposed surface (Figure 1a), it is possible to 
detect the presence and distribution of elemental 
carbon, expected from, and after loading, (S) (+) 
ibuprofen; a uniform distribution can be seen 
through (Figure 1b) the layer at the points sampled 
shown in Figure 1a. 
 
Figure 1a. Cross-sectional SEM image of a loaded 












Figure 1b. Cross-sectional EDX spectra showing ‘C’ 
and ‘O’ after loading with Ibuprofen (peaks 
normalised to that of Si, shown for comparison).  
 
Unloaded aerocrystal flakes biodegraded into 
silicic acid in-vitro with much faster kinetics than 
air-dried controls. This was consistent with the 
higher pore volumes and surface areas attained via 
supercritical drying. The release profile of 
aerocrystal loaded Ibuprofen microparticles is 
compared to bulk Ibuprofen microparticles in Figure 
2. A significant improvement in dissolution rate was 
observed as a result of mesopore entrapment. 
 
Figure 2. Release profile comparing (S) (+) 
ibuprofen loaded aerocrystal and bulk (S) (+) 
ibuprofen; USP type II, 50rpm, Phosphate buffer 
(pH 7.2), 37±1⁰C, sampling volume 2mL.  
 
For such aerocrystal matrices, the maximum 
payload of small molecule drugs scales with pore 
volume and drug density within the mesopores. An 
even higher payload of 85±2%w/w has been 
achieved from preliminary melt loading studies with 
triclosan, an antibacterial, and our highest pore 
volume material (Figure 1a). 
 
CONCLUSION 
The ability of silicon-based aerocrystals to carry 
very high drug payloads and to be loaded by simple 
techniques has been demonstrated for the first time.  
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